Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13013342 | 0.95 | MEN1 (0.44) | LMNAKDM4EMEN1MAPTOPRK1 | |
| SCHEMBL13137367 | 0.92 | PDK2 (0.38) | LMNAKDM4EMEN1MAPTOPRK1 | |
| SCHEMBL12124347 | 0.92 | PDK2 (0.36) | LMNAKDM4EMEN1MAPTOPRK1 | |
| SCHEMBL13766216 | 0.92 | PDK2 (0.41) | LMNAKDM4EMEN1MAPTOPRK1 | |
| SCHEMBL15975762 | 0.90 | PDK2 (0.32) | — | |
| SCHEMBL13137372 | 0.89 | ESR1 (0.36) | LMNAKDM4EMEN1MAPTOPRK1 | |
| SCHEMBL13766241 | 0.87 | PDK2 (0.35) | ESR1ESR2 | |
| SCHEMBL15762295 | 0.85 | LMNA (0.40) | LMNAKDM4EMEN1MAPTOPRK1 | |
| SCHEMBL5833238 | 0.85 | KDM4E (0.36) | LMNAKDM4EMEN1MAPTOPRK1 | |
| SCHEMBL5837635 | 0.85 | KDM4E (0.36) | LMNAKDM4EMEN1MAPTOPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1745113-B1 | NOVEL MATERIAL MIXTURES FOR USE IN ELECTROLUMINESCENCE | MERCK PATENT GMBH (DE) | 2016-10-26 | — | — | EP | disclosed |
| US-8058790-B2 | Material mixtures for use in electroluminescence | MERCK PATENT GMBH (DE) | 2011-11-15 | — | — | US | disclosed |
| US-7799440-B2 | Organic electroluminescent device and host material of luminescent and hole-blocking material thereof | CHI MEI OPTOELECTRONICS CORP. (TW) | 2010-09-21 | — | — | US | disclosed |
| US-7799440-B2 | Organic electroluminescent device and host material of luminescent and hole-blocking material thereof | CHI MEI OPTOELECTRONICS CORP. (TW) | 2010-09-21 | — | — | US | disclosed |
| US-20090189519-A1 | Organic electroluminescent compounds and light emitting diode using the same | GRACEL DISPLAY INC. (KR) | 2009-07-30 | — | — | US | disclosed |
| US-20070176147-A1 | Novel material mixtures for use in electroluminescence | MERCK PATENT GMBH (DE) | 2007-08-02 | — | — | US | disclosed |
| US-20070015005-A1 | Organic electroluminescent device and host material of luminescent and hole-blocking material thereof | CHI MEI OPTOELECTRONICS CORP. (TW) | 2007-01-18 | — | — | US | disclosed |
| US-20070015005-A1 | Organic electroluminescent device and host material of luminescent and hole-blocking material thereof | CHI MEI OPTOELECTRONICS CORP. (TW) | 2007-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090189519-A1 | Organic electroluminescent compounds and light emitting diode using the same | OCIAD1, AOX1, OCIAD2 | LMNA 2608/4885KDM4E 2502/4885MEN1 2706/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.